ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Improved cancer immunotherapy strategies by nanomedicine

Guo, Shuai; Feng, Jie*; Li, Zongheng; Yang, Sugeun; Qiu, Xiaozhong*; Xu, Yikai*; Shen, Zheyu南方医科大学
Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology2023-5DOI: 10.1002/wnan.1873
6被引10阅读
引用收藏
分享

摘要

Cancer immunotherapy agents fight cancer via immune system stimulation and have made significant advances in minimizing side effects and prolonging the survival of patients with solid tumors. However, major limitations still exist in cancer immunotherapy, including the inefficiency of immune response stimulation in specific cancer types, therapy resistance caused by the tumor microenvironment (TME), toxicities by the immune imbalance, and short lifetime of stimulator of interferon genes (STING) agonist. Recent advances in nanomedicine have shown significant potential in overcoming the obstacles of cancer immunotherapy. Several nanoscale agents have been reported for cancer immunotherapy, including nanoscale cancer vaccines impacting the STING pathway, nanomaterials reprogramming TME, nano-agents triggering immune response with immune checkpoint inhibitor synergy, ferroptosis-mediated and indoleamine-2,3-dioxygenase immunosuppression-mediated cancer immunotherapy, and nanomedicine-meditated chimeric antigen receptor-T-cell therapy. Herein, we summarize the major advances and innovations in nanomedicine-based cancer immunotherapy, and outline the opportunities and challenges to integrate more advanced nanomaterials into cancer immunotherapy.This article is categorized under:Nanotechnology Approaches to Biology > Nanoscale Systems in BiologyTherapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic DiseaseTherapeutic Approaches and Drug Discovery > Emerging Technologies

学科与关键词

关键词
cancer immunotherapychimeric antigen receptor-T cellsferroptosisimmune checkpoints inhibitorsindoleamine-23-dioxygenase immuno-suppressionmRNA vaccinesnanomedicinestimulator of interferon genestumor microenvironment
相关
加载中…
  • Nanomedicine-based cancer immunotherapy: recent trends and future perspectives
    Lakshmanan, Vinoth-Kumar*; Jindal, Shlok; Packirisamy, Gopinath*; Ojha, Shreesh; Lian, Sen; Kaushik, Ajeet; Alzarooni, Abdulqadir Ismail M. Abdullah; Metwally, Yasser Abdelraouf Farahat; Thyagarajan, Sadras Panchatcharam; Jung, Young Do; Chouaib, Salem*Cancer Gene Therapy, 2021, 28(9): 911-923.被引 38
  • Engineered metal and their complexes for nanomedicine-elicited cancer immunotherapy
    Wang, Yushu; Wang, Bin; Li, Kao; Wang, Maosheng*; Xiao, Haihua*Materials Today Advances, 2022, 15: 100276.被引 7
  • Nanomaterials: A powerful tool for tumor immunotherapy
    Chen, Ziyin; Yue, Ziqi; Wang, Ronghua; Yang, Kaiqi; Li, Shenglong*Frontiers in Immunology, 2022, 13: 979469.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
发表日期
2023-05
卷期
第 15 卷, 第 3 期
DOI
10.1002/wnan.1873
语言
ENGLISH
成果收录
SCIE
资助标注
Guangdong Provincial Natural Science Foundation of China [2021A1515010605]; Guangzhou Key Research and Development Program of China [202103000094]; Zhejiang Provincial Natural Science Foundation of China [LR19E030001]

作者

  • G

    Guo, Shuai (第一作者)

    southern med univ

  • F

    Feng, Jie (通讯)

    southern med univ

查看全部 7 位作者收起作者
  • L

    Li, Zongheng

    southern med univ

  • Y

    Yang, Sugeun

  • Q

    Qiu, Xiaozhong (通讯)

    southern med univ

  • X

    Xu, Yikai (通讯)

    southern med univ

  • S

    Shen, Zheyu

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417